Shares of Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.04 and traded as high as $0.08. Anthera Pharmaceuticals shares last traded at $0.07, with a volume of 30,057 shares.
The stock has a 50 day simple moving average of $0.09 and a 200-day simple moving average of $0.04.
Anthera Pharmaceuticals Company Profile (OTCMKTS:ANTH)
Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Featured Article: How does quantitative easing work?
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.